Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

Dose-Response Relationship: Overview

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...

Uncertainty: Confidence Intervals

Uncertainty: Confidence Intervals

The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Dose Size and Dosing Frequency: Determination Methods

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Polygenic liability for schizophrenia and childhood adversity influences daily-life emotion dysregulation and psychosis proneness.

Acta psychiatrica Scandinavica·2020

Same author

[Text message reminders in the hospital-psychiatry outpatient setting - a quasi-experimental study on cost aspects].

Tijdschrift voor psychiatrie·2018

Same author

Simultaneous confidence bounds for relative risks in multiple comparisons to control.

Statistics in medicine·2010

Same author

Testing marginal homogeneity against stochastic order in multivariate ordinal data.

Biometrics·2008

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Proof of concept and dose estimation with binary responses under model uncertainty.

B Klingenberg¹

¹Department of Mathematics and Statistics, Williams College, Williamstown, MA 01267, USA. bklingen@williams.edu

Statistics in Medicine

|November 18, 2008

Summary

This study introduces a new framework for clinical trials to test Proof of Concept (PoC) and estimate optimal drug doses. The method offers a more powerful and flexible analysis than traditional tests, incorporating model uncertainty for better results.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

Biostatistics
Clinical Trial Design
Pharmacometrics

Background:

Traditional methods for Proof of Concept (PoC) testing and dose estimation in clinical trials often lack robustness and flexibility.
Existing tests like Cochran-Armitage or Dunnett are optimal only for specific dose-response shapes and do not provide confidence intervals for dose estimates.

Purpose of the Study:

To propose a unified framework for robust Proof of Concept (PoC) testing and target dose estimation in Phase II clinical trials.
To develop a method that incorporates model uncertainty and provides confidence intervals for dose estimates, improving upon existing approaches.

Main Methods:

A novel framework is presented that selects the best-fitting models from a candidate set to describe observed dose-response data.
Permutation distribution of the minimum P-value is used to control the familywise error rate for declaring significant dose effects.
Model averaging is employed for target dose estimation, integrating uncertainty into the decision-making process.

Main Results:

The proposed framework demonstrates comparable or superior power to traditional tests in detecting dose-responses across various shapes.
The method effectively controls the familywise error rate, preventing spurious findings.
It provides confidence intervals for target dose estimates, a feature lacking in many standard tests.

Conclusions:

The unified framework offers a more comprehensive, robust, and powerful approach to PoC testing and dose estimation in clinical trials.
This method enhances decision-making by incorporating model uncertainty and providing reliable confidence intervals.
The framework is adaptable to complex data structures and offers significant advantages over conventional statistical tests.